Stockscreener 앱 받기
4.90
3.35%
-0.17
시간 외 거래:
4.90
Nuvectis Pharma Inc (NVCT) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Research and Development |
37.63%
2.66
|
4.265 | 4.486 | 4.262 | 2.367 |
| Operating Income/Loss |
35.97%
-4.396
|
-6.866 | -6.158 | -5.772 | -4.101 |
| Income/Loss From Continuing Operations Before Tax |
37.01%
-4.171
|
-6.622 | -5.881 | -5.708 | -4.049 |
| Income/Loss From Continuing Operations After Tax |
37.01%
-4.171
|
-6.622 | -5.881 | -5.708 | -4.049 |
Net Income/Loss
|
37.01%
-4.171
|
-6.622 | -5.881 | -5.708 | -4.049 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
7,603%
16.56
|
0.215 | 16.10 | 15.18 | 14.72 |
| Diluted Average Shares |
7,603%
16.56
|
0.215 | 16.10 | 15.18 | 14.72 |
| Basic Earnings Per Share |
39.02%
-0.25
|
-0.41 | -0.37 | -0.38 | -0.27 |
| Diluted Earnings Per Share |
39.02%
-0.25
|
-0.41 | -0.37 | -0.38 | -0.27 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.93%
3.55%
자본화:
|
볼륨(24시간):